The most eye-catching news making the rounds currently is the initial public offering of the Newsmax channel, which took place when the bell rang on March 31st.  The stock rose an astonishing 735% on the first day of public trading and then rose another 60% on the second day.  The investment bankers were asking for $14 a share in the initial offering, but by the end of the second day, some investors were paying more than $200.

This is the sort of headline that makes investors think about getting on the ground floor of newly issued stock shares.  Who isn’t envious of a 700% return on investment in one day?  

The problem with initial public offerings is exactly what this implies: a segment of the investing public is eager to buy, sometimes at any price, and the result is a sugar-high price surge that eventually settles down, often further down, than the initial share price.  One only must ponder for a moment: the investment bankers that took the company public valued it at $14 a share.  Were they that wrong about the realistic price?  And would the company have voluntarily given up billions of dollars that it could have put in its coffers if they believed that the initial price matched the price on the second day of trading?  

There might be a hint of an answer in the fact that none of the online valuation services were willing, at that point, to post a price/earnings ratio for Newsmax, possibly because the amount eager new Newsmax shareholders were paying for a dollar in earnings was stretched far beyond normal measures.

Looking more broadly at IPO investing, the curious investor can find a list of all 225 companies that went public last year, their IPO price and the price their shares are trading at today.  Investors might have been eager to get in on the ground floor of Health in Tech, Inc., but if they did, they’d be experiencing an 83.45% loss as of today.  Other IPO investments that were not ideal for your portfolio include Linkers Industries, Ltd. (-85.91%), Jupiter Neurosciences (-84.45%), Brazil Potash Corp. (-80.40%), Heritage Distilling Holding Company (-88.85%), Wellchange Holdings Company (-93.50%) and Kairos Pharma (-78.63%).  In all, 122 of the 225 have been market losers, often by large amounts; between 50% and 90%.  Many of the exceptions basically broke even.

The point here is that getting in on the ground floor of a company that is trading on the markets for the first time is extremely risky business.  In fact, Newsmax as of May 2nd, 2025 closed at $22.94, a far cry from the $200 excited investors paid for a share.

This article was written by an independent writer for Brewster Financial Planning LLC and is not intended as individualized legal or investment advice.